HIV/AIDS News

An intervention that included sessions with community health workers improved viral load and reduced alcohol use among youth with HIV, according to a study published in JAMA Network Open.

The Infectious Diseases in Children Symposium will shift from an in-person to a virtual format for 2020, organizer Healio LIVE announced.

Screening young men who have sex with men every 3 months for HIV is cost effective and improves clinical outcomes compared with less frequent screening, researchers reported in Clinical Infectious Diseases.

Children with HIV aged between 3 and 9 years maintained virologic suppression on a low-dose, single-tablet regimen of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide, researchers reported.

The results of five randomized controlled trials showed greater and faster rates of virologic suppression among pregnant women with HIV who took dolutegravir compared to those who took efavirenz, researchers reported at AIDS 2020.

Zimbabwean adolescent girls and young women who graduated from a program supporting girls-only clubs were more likely to take an HIV test and less likely to drop out of school, among other positive outcomes, researchers reported.

Martina Penazzato, MD, PhD, DTMH, MSc, reviewed the obstacles that stand in the way of an “AIDS-free generation” in her presentation on pediatric HIV during the International AIDS Conference, while also highlighting potential solutions.

During an International AIDS 2020 press conference today, Anthony S. Fauci, MD, said that, before the COVID-19 pandemic, the idea of a highly contagious respiratory illness was many infectious disease physicians’ “worst nightmare.”

An HIV outbreak among children in Sindh, Pakistan, was associated with multiple recent injections or infusions, blood transfusion and a higher number of visits to health care facilities, according to results of a case-control study.

Tenofovir alafenamide with emtricitabine and dolutegravir, or TAF/FTC+DTG, and tenofovir disoproxil fumarate, or TDF, and FTC+DTG resulted in similar efficacy to TDF, FTC and efavirenz, or EFV, among people with HIV in South Africa.